GlassScriptPhysician profile
Stephanie Marcus
NPI 1720427487
$640.48
in general payments reported to CMS, 2019-2025
11 companies · $116 in 2025
The $116 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.35 · 2020: $25.11 · 2021: $43.68 · 2022: $71.90 · 2023: $186 · 2024: $165 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $121.96 | 2021-2025 | Doc Band |
| Pfizer INC. | $97.95 | 2022-2025 | |
| Corium, LLC | $96.68 | 2024-2025 | Azstarys |
| Alk-Abello, INC | $94.96 | 2023-2025 | Grastek, Odactra, Ragwitek |
| Genentech USA, INC. | $66.76 | 2019-2022 | |
| Kaleo, INC. | $47.18 | 2019-2023 | Auvi-Q |
| Sanofi Pasteur INC. | $36.03 | 2021-2025 | |
| Neurelis, INC. | $24.62 | 2022 | |
| Ironshore Pharmaceuticals INC. | $23.95 | 2023 | Jornay Pm |
| Seqirus USA INC | $16.42 | 2023 | Flucelvax Quadrivalent |
| Phadia US INC. | $13.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.